简体中文

·腹部疾病·

恶性梗阻性黄疸PTBD对免疫功能影响的前瞻性对照研究

作者:张东坡1 李建军1 戴定可2 于 平2 翟仁友2

所属单位:1.北京市垂杨柳医院放射科 (北京 100022) 2.首都医科大学附属北京朝阳医院放射科 (北京 100020)

PDF

摘要

目的 通过前瞻性临床对照研究,比较经皮肝穿胆道引流术不同引流方法治疗恶性梗阻性黄疸对免疫功能的影响。 方法 自2006年3月-2007年2月应用PTBD治疗符合入组标准的恶性梗阻性黄疸病例91例,男57例,女34例,年龄 30-81岁,平均(60.4±11.6)岁。行PTIEBD(内外引流)的患者随机入组:IED-A组(餐后关闭引流2小时)20例、IED-B 组(日间关闭引流)20例、IED-C组(持续关闭引流)15例;行PTEBD(外引流)患者36例。对术前3天内、术后2-4天、术 后8-10天、术后1个月外周血总T细胞(TC)、辅助性T细胞(TH)、抑制性T细胞(TS)及TH/TS、免疫球蛋白(IgG, IgA, IgM)进行统计学方差分析。结果 术前3天内各组各免疫指标差异无显著性(P>0.05)。术后1个月TC、TH及TH/TS水平 IED-B组>IED-A组>ED组,各组间比较均有显著性差异(P<0.05)。术后1个月IgG、IgA水平ED组>IED-A组>IED-B组, IED-B组与ED组间差异具有统计学意义(P<0.05)。术后1个月较术前TC、TH及TH/TS、IgG、IgA水平IED-A组、IED-B 组均有明显恢复,差异有统计学意义(P<0.05),ED组差异无统计学意义(P<0.05)。IED-C组TC、TH及TH/TS、IgG、 IgA水平术后2-4天与术前比较,差异无明显统计学意义(P>0.05)。结论 IED-A组、B组术后梗黄患者免疫功能可明 显恢复,其中IED-B组效果较好;ED组及IED-C组梗黄患者免疫功能无明显恢复。

Objective To evaluate the effect of the different methods of PTBD on immunity to treat the patients with the malignant obstructive jaundice throught this prospective clinical control study. Methods There are 91 consecutive cases with the malignant objective jaundice (M:F=57:34), mean age (60.4±11.6 years) who were selected by our standard were accepted PTBD therapy from 2006.3 to 2007.2. The patients who undergo PTIEBD will be send into three group at random: group IED-A(turn off drainage for 2 hours after each meal) 20 cases, group IED-B(turn off drainage duaring daytime) 20 cases, group IED-C(turn off drainage persistently) 15 cases. Thirty-six patients underwent PTIEBD. TC, TH, TS, TH/TS, IgG, IgA, IgM before operation and 2-4 days, 8-10 days, and 1 month after the operation were analyzed by ANOVA test. Results There is no obvious difference in TC, TH, TS, TH/TS, IgG, IgA, IgM among these groups before operation(P>0.05). At 1 month after PTBD, the level of TC, TH, TH/TS: group IED-B>group IEDA>group ED, and the difference between three group is obvious(P<0.05); the level of IgG, IgA: group ED>group IEDA>group IED-B, and comparing group ED with group IED-B, the difference is obvious(P<0.05). At 1 month after PTBD, the level of TC, TH, TH/TS, IgG, IgA has been improved in group IED-A and group IED-B obviously(P<0.05). TC, TH, TH/TS, IgG, IgA did not change obviously after operation in IED-C group(P>0.05). Conclusion The immunity can be improved in group IED-A,B obviously, and group IED-B is better than group IED-A. In group ED and group IED-C, the immunity cann’t be improved obviously.

【关键词】黄疸/梗阻性;经皮肝穿胆道引流术;放射学/介入性;细胞免疫;体液免疫

【中图分类号】R256.41

【文献标识码】A

【DOI】10.3969/j.issn.1009-3257.2015.04.009

前言

研究表明[1],恶性梗阻性黄疸患者免疫系统会受 到明显的抑制。胆道内引流在治疗梗阻性黄疸时机 体免疫功能可以得到有效恢复,而外引流则不能有效提高阻黄机体的免疫功能[2]。由于国内外对经皮肝 穿胆道外引流术(PTEBD)与经皮肝穿胆道内外引流术 (PTIEBD)不同引流方法对机体免疫功能影响的对照研究甚少,本研究通过前瞻性、对照的临床试验,旨在 比较PTEBD与PTIEBD及其不同引流方法治疗恶性梗阻 性黄疸对机体免疫功能影响的近期疗效。